Mission
THE MISSION OF THE OSTEOSARCOMA INSTITUTE IS TO DRAMATICALLY INCREASE TREATMENT OPTIONS AND SURVIVAL RATES IN OSTEOSARCOMA PATIENTS THROUGH IDENTIFYING AND FUNDING THE MOST PROMISING AND BREAKTHROUGH OSTEOSARCOMA CLINICAL TRIALS AND SCIENCE.
Public Charity
THE OSTEOSARCOMA INSTITUTE
THE OSTEOSARCOMA INSTITUTE, of DALLAS, TX, is a Public Charity tracked in Imperigo's IRS 990 database. The 2024 filing shows $4.2M in revenue, $2.7M in expenses, $6.3M in total assets. 23 publicly reported grants to this organization, totaling roughly $4.6M, appear in IRS filings.
EIN: 822921815
DALLAS, TX
Latest filing: 2024
Total Revenue$4.2M
Total Expenses$2.7M
Total Assets$6.3M
Grant Records23
Funding Total$4.6M
Filing Years2019–2024
Sample Grants Received
THIS GRANT IS DESIGNATED FOR GENERAL SUPPORT.
$3,316,000
$334,550
TO FURTHER CANCER RESEARCH
$38,519
DONATION
$25,000
CHARITABLE DONATION
$21,119
Showing up to 5 of 23 total records — full history available with membership.
Officers & Directors
BOARD OF TRUSTEES
Alli Murdoff
INSTITUTE DIRECTOR
Lee Helman
BOARD OF TRUSTEES
Lisa Tichenor
BOARD OF TRUSTEES
Mary Katherine Clarke
CHAIR OF BOARD OF TRUSTEES
Mchenry Tichenor Jr
BOARD OF TRUSTEES
Michael Egge
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $4.2M | $2.7M | $6.3M |
| 2023 | $1.4M | $2.7M | $4.8M |
| 2022 | $750K | $1.4M | $6.1M |
| 2020 | $454K | $1.1M | $8.3M |
| 2019 | $376K | $341K | $9.0M |
Between 2019 and 2024, reported annual revenue grew from $376K to $4.2M (+1009%), with total assets most recently reported at $6.3M.
Interactive year-over-year charts and full filing details available with membership.